Journal profile · Endocrinology & Metabolism
Cardiovascular Diabetology
ISSN 1475-2840 · BioMed Central · ENGLAND · Irregular · Founded 2002
Cardiovascular Diabetology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 15.53; fully open access; APC about USD 4,490; median 65 days to acceptance (119 articles, last 24 months); 495 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cardiovascular Diabetology is published by BioMed Central and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiovascular Function and Risk Factors and Diabetes Treatment and Management, together about 39.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Enrique FismanPublisher website
Editorial board by country: 19 in mainland China (about 18%); most named Mainland China 19, Italy 14, United States 12, Israel 9, Japan 7 (107 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine14.6%
- Cardiovascular Function and Risk FactorsMedicine13.3%
- Diabetes Treatment and ManagementMedicine11.9%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine7.5%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine6%
- Cardiovascular Disease and AdiposityMedicine4.8%
- Cardiovascular Health and Disease PreventionMedicine4.2%
- Diabetes Management and ResearchMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 15.53LetPub ·
- Impact factor (publisher) 2025
- 15.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 13.6Publisher website ·
- CiteScore 2026-06
- 18.7LetPub ·
- SJR 2026-06
- 4.45LetPub ·
- SNIP 2026-06
- 3.01LetPub ·
- h-index
- 64LetPub ·
- h-index
- 170OpenAlex ·
- i10-index
- 3,162OpenAlex ·
- 2-year mean citedness
- 17.5OpenAlex ·
- Self-citation rate
- 14.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 464LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 5,900,000Publisher website ·
Articles by year OpenAlex count · 4,157 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 334 | 334 | 571 |
| 2025 | 495 | 495 | 8,048 |
| 2024 | 456 | 456 | 13,867 |
| 2023 | 353 | 353 | 15,675 |
| 2022 | 294 | 294 | 16,483 |
| 2021 | 244 | 244 | 14,093 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
65 daysMedian, submission to acceptance · P25–P75 47 days – 87 days
- Acceptance to online
- median 17 days (119 articles)
- Submission to online
- median 88 days
- Sample
- 119 articles with submission and acceptance dates (925 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,990 / USD 4,490 / GBP 3,390 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 4,290 / EUR 3,690 / GBP 3,190 | — | — | |
| LetPub | GBP 2,990 / USD 3,990 / EUR 3,390 | Yes | — | |
| Publisher website | GBP 3,390 / USD 4,490 / EUR 3,990 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
- Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Risk Stratification, Prognostic Implications and Therapeutic InnovationDeadline
- Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic LandscapeDeadline
- Vascular Drivers of Cardio-Metabolic Disease: Mechanisms and Clinical ImplicationsDeadline
What to prepare3 items from the author guidelines
- Reference style
- Vancouver
- Templates
- LaTeX and Word
- Suggested reviewers
- Optional
Article types accepted8
- case reportResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- commentResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- hypothesisResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- matters arisingResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- methodology articleResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- researchResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- reviewResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
- study protocolResearch Review Case report Comment Hypothesis Methodology article Study protocol Matters ArisingLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required; deposit in public repositories where appropriate. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Cardiovascular Diabetology articles are published open access under a CC BY-NC-ND (Creative Commons Attribut…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Irregular
- Founded
- 2002
- ISSN
- 1475-2840
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardiovascular Diabetology
What CAS zone is Cardiovascular Diabetology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiovascular Diabetology is in Zone 1 of Medicine, and in Zone 1 of the minor category Endocrinology & Metabolism / Cardiac & Cardiovascular Systems; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiovascular Diabetology?
The latest impact factor listed by LetPub is 15.53; CiteScore 18.7, h-index 170.
How long does peer review take at Cardiovascular Diabetology?
Based on the dates recorded on 119 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 65 days (interquartile range 47–87 days); authors report an average review time of about 1 month. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cardiovascular Diabetology?
According to the journal's author guidelines: Reference style: Vancouver; Templates: LaTeX and Word; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cardiovascular Diabetology based?
Of the 107 board members whose country the journal's board page names, 19 (about 18%) are in mainland China; the countries named most often are Mainland China (19), Italy (14) and United States (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiovascular Diabetology?
According to LetPub and DOAJ records, Cardiovascular Diabetology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Cardiovascular Diabetology open access, and what is the APC?
Cardiovascular Diabetology is a fully open-access journal. APC about USD 4,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .